Stock listing
0PB Stock Price, News, Filings & Events — Puma Biotechnology Inc
Selected listing: 0PB · TRADEGATE · EUR · DE
This page tracks Puma Biotechnology Inc's 0PB:TRADEGATE listing on TRADEGATE in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 0PB:TRADEGATE. 0PB:TRADEGATE is the stock-level entry point for investors researching Puma Biotechnology Inc, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Puma Biotechnology Inc (PBYI) is a public company based in the United States, focusing on the development and commercialization of innovative cancer therapies. With a market capitalization of approximately $434.2 million, Puma aims to address unmet medical needs in oncology. The company is committed to advancing its pipeline of targeted treatments for patients with various types of cancer.

- Ticker
- 0PB:TRADEGATE
- Asset type
- Stock
- Market cap
- $434.2M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- TRADEGATE
- Currency
- EUR
Puma Biotechnology Inc 0PB:TRADEGATE stock context
This page tracks Puma Biotechnology Inc's 0PB:TRADEGATE listing on TRADEGATE in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 0PB:TRADEGATE. 0PB:TRADEGATE is the stock-level entry point for investors researching Puma Biotechnology Inc, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Puma Biotechnology Inc (PBYI) is a public company based in the United States, focusing on the development and commercialization of innovative cancer therapies. With a market capitalization of approximately $434.2 million, Puma aims to address unmet medical needs in oncology. The company is committed to advancing its pipeline of targeted treatments for patients with various types of cancer.
Research Puma Biotechnology Inc
Puma Biotechnology Inc investor report
Review AI stock analysis and investor report context for 0PB:TRADEGATE.
Puma Biotechnology Inc company profile
View the public company page for Puma Biotechnology Inc on 6ix.
Puma Biotechnology Inc news
Read company news and market updates connected to Puma Biotechnology Inc.
Puma Biotechnology Inc investor events
Find investor webinars, events, and replay context for Puma Biotechnology Inc.